[Ipriflavone in the treatment of osteoporosis].
Makita
Kazuya
K
Department of Obstetrics & Gynecology, School of Medicine, Keio University.
Ohta
Hiroaki
H
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D002986:Clinical Trials as Topic; D005265:Femoral Neck Fractures / Q000517:prevention & control; D015775:Fractures, Stress / Q000517:prevention & control; D006801:Humans; D007529:Isoflavones / Q000494:pharmacology / Q000627:therapeutic use*; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D016103:Spinal Fractures / Q000517:prevention & control
D007529:Isoflavones; C018986:ipriflavone